Periodontal changes in liver cirrhosis and post-transplantation patients. I: Clinical findings

Journal of Periodontology

Volumn 72, Issue 9, 2001, Pages 1236-1240

  Oettinger Barak, Orit ^a   Barak, Shlomi ^b   Machtei, Eli E ^a,b   Ardekian, Leon ^b   Baruch, Yaacov ^b   Peled, Micha ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cross sectional studies; Cyclosporin A adverse effects; Gingival hyperplasia etiology; Immunosuppression; Liver cirrhosis; Liver transplantation; Tacrolimus adverse effects

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFECT; FEMALE; GINGIVA HYPERPLASIA; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; POSTOPERATIVE COMPLICATION; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; CYCLOSPORINE; FEMALE; GINGIVAL HYPERPLASIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TACROLIMUS;

EID: 0034821291     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.72.9.1236     Document Type: Article

References (30)

1. Schwartz S, Shires T, Spencer F. Transplantation. In: Schwartz SI, ed. Principles of Surgery, 6th ed. New York: McGraw-Hill, Inc.; 1994:414-419.
2. Sponholz A, Nawthbohm K, Brugmann E, Maass M. Correlations between chronic liver disease and periodontal diseases with special reference to animal experiments. Stomatol DDR 1976;26:409-413.
3. Barbero P, Garzino Demo MG, Milanesio M, Ottobrelli A. The dental assessment of the patient waiting for liver transplant. Minerva Stomatol 1996;45:431-439.
4. Novacek G, Plachetzky U, Potzi R, et al. Dental and periodontal disease in patients with cirrhosis-role of etiology of liver disease. J Hepatol 1995;22:576-582.
5. Movin S. Relationship between periodontal disease and cirrhosis of the liver in humans. J Clin Periodontol 1981; 8:450-458.
6. Britton S, Palacios R. Cyclosporin A - usefulness, risks and mechanism of action, Immunol Rev 1982;65:5-22.
7. Kino T, Hatanaka H, Hashimoto M. FK-506, a novel immunosuppressant isolated from a Streptomyces: I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 1987;40:1249-1255.
8. Tyldeseley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
9. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. J Clin Periodontol 1987;14:610-613.
10. Daley TD, Wysocki GP, May C. Clinical and pharmacological correlations in cyclosporin-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62: 417-421.
11. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
12. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18: 107-110.
13. Williams R, Neuhaus P, Bismuth H, et al. Two-year data from the European multicentre tacrolimus (FK506) liver study. Transpl Int 1996;9(Suppl. 1):S144-S150.
14. Bader G, Lejeune S, Messner M. Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus. A case history involving a liver transplant patient. J Periodontol 1998;69:729-732.
15. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000;27: 144-148.
16. Thorp M, DeMattos A, Bennett W, Barry J, Norman D. The effect of conversion from cyclosporin A to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. Transplantation 2000;69:1218-1220.
17. Ramfjord SP. Indices for prevalence and incidence of periodontal disease. J Periodontol 1959;30:57.
18. Silness P, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
19. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
20. Löe H. The gingival index, the plaque index and the retention index systems. J Pedodontol 1967;38:610-616.
21. Seymour RA, Smith DG, Turnbull DN. The effects of phenytoin and sodium valporate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985; 12:413-419.
22. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18: 353-358.
23. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-274.
24. Liu CM, Hou LT, Wong MY, Rossomando EF. Relationships between clinical parameters, interleukin-1β and histopathologic findings of gingival tissue in periodontitis patients. Cytokine 1996;8:161-167.
25. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and 1L-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998;69:899-910.
26. van der Zee E, Everts V, Beertsen W. Cytokines modulate routes of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. J Clin Periodontol 1997;24:297-305.
27. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1β and interleukin-6 expression in gingiva: Implications for gingival overgrowth. J Periodontol 1999;70:294-300.
28. Atilla G, Kutukçuler M. Crevicular fluid interleukin-1β, tumor necrosis factor-α, and interleukin-6 levels in renal transplant patients receiving cyclo sporine A. J Periodontol 1998:69:784-790.
29. Sinha-Morton R, Dongari-Bagtzoglou AI. Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A. J Periodontol 1999;70:1464-1471.
30. Gines P, Fernandez-Esparrach G, Arroyo V, Rodes J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis 1997;17:175-189.